Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines
Abstract Global vaccination programs using live-attenuated oral and inactivated polio vaccine (OPV and IPV) have almost eradicated poliovirus (PV) but these vaccines or their production pose significant risk in a polio-free world. Recombinant PV virus-like particles (VLPs), lacking the viral genome,...
Saved in:
Main Authors: | Mohammad W. Bahar, Claudine Porta, Helen Fox, Andrew J. Macadam, Elizabeth E. Fry, David I. Stuart |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/6d14a9581b7346d2a0e7c0c7fcf06ddd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plant-made polio type 3 stabilized VLPs—a candidate synthetic polio vaccine
by: Johanna Marsian, et al.
Published: (2017) -
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses
by: Rahnuma Wahid, et al.
Published: (2021) -
Polio postgraduate course
by: Editorial Office
Published: (1955) -
CHALLENGES FOR POLIO ERADICATION. RISK OF RE-EMERGENCY OF INFECTION IN POLIO FREE COUNTRIES
by: N. I. Romanenkova, et al.
Published: (2018) -
Salk Anti-Polio Vaccine
Published: (2017)